JNGLX
Price
$66.99
Change
-$0.85 (-1.25%)
Updated
Apr 3 closing price
Net Assets
4.95B
LHCAX
Price
$17.75
Change
-$0.43 (-2.37%)
Updated
Apr 3 closing price
Net Assets
7.48M
Ad is loading...

JNGLX vs LHCAX

Header iconJNGLX vs LHCAX Comparison
Open Charts JNGLX vs LHCAXBanner chart's image
Janus Henderson Global Life Sciences D
Price$66.99
Change-$0.85 (-1.25%)
VolumeN/A
Net Assets4.95B
Lord Abbett Health Care A
Price$17.75
Change-$0.43 (-2.37%)
VolumeN/A
Net Assets7.48M
JNGLX vs LHCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LHCAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and LHCAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.95B vs. LHCAX (7.48M). JNGLX (0.34) and LHCAX (0.33) have matching dividends . JNGLX was incepted earlier than LHCAX: JNGLX (26 years) vs LHCAX (6 years). LHCAX (3.53) is less costly to investors than JNGLX (0.80). LHCAX is a more actively managed with annual turnover of: 88.00 vs. JNGLX (35.00). LHCAX has a lower initial minimum investment than JNGLX: LHCAX (1500) vs JNGLX (2500). LHCAX annual gain was more profitable for investors over the last year : -3.68 vs. JNGLX (-6.47). JNGLX return over 5 years is better than : 35.26 vs. LHCAX (30.80).
JNGLXLHCAXJNGLX / LHCAX
Total Expense Ratio0.801.0378%
Annual Report Gross Expense Ratio0.803.5323%
Fund Existence26 years6 years-
Gain YTD-0.074-5.1151%
Front LoadN/A6%-
Min. Initial Investment25001500167%
Min. Initial Investment IRAN/AN/A-
Net Assets4.95B7.48M66,114%
Annual Yield % from dividends0.340.33103%
Returns for 1 year-6.47-3.68176%
Returns for 3 years2.62-1.76-149%
Returns for 5 years35.2630.80114%
Returns for 10 years18.94N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FKEMX37.89N/A
N/A
Fidelity Emerging Markets K
VEUCX30.10N/A
N/A
JPMorgan Europe Dynamic C
GGGCX44.97N/A
N/A
Gabelli Global Growth C
AVPEX13.04N/A
N/A
ALPS Global Opportunity Portfolio Cl III
NRAEX47.79N/A
N/A
Neuberger Berman Sustainable Equity E